Miao Wang (王淼), PhD，FAHA

Professor of Pharmacology,

Chinese Academy of Medical Sciences & Peking Union Medical College

Professional Field: Translational research in cardiovascular inflammation, drug discovery

           

Dr. Wang is a professor and principal investigator of the Laboratory of Vascular Biology and Pharmacology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Peking Union Medical College (PUMC) & Chinese Academy of Medical Sciences (CAMS). He obtained a Ph.D. from PUMC & CAMS in 2002. Dr. Wang completed postdoctoral research and obtained a Clinical Research Certificate in Clinical Epidemiology & Biostatistics, at University of Pennsylvania, and then joined the faculty of the Department of Pharmacology, as Research Associate and Research Assistant Professor from 2006-2010.

 

Dr. Wang then joined Pfizer Inc as Principal Scientist, and had been leading a new drug discovery program in the Cardiovascular and Metabolic Disease Research Unit until taking his current position.

 

Dr. Wang serves in the program committee of American Heart Association (AHA) Scientific Sessions and of Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions. He is fellow of AHA (FAHA), a lifetime member of Chinese American Academy of Cardiology (CAAC) and Sino-American Pharmaceutical Professionals Association (SAPA). He is standing member of Gerontology Council, China Association of Gerontology and Geriatrics, committee member of Thrombosis and Hemostasis Council, Chinese Association for Physiological Sciences, and Committee Member of Receptors and Signal Transduction Council, Chinese Association for Pathophysiology. He won SAPA Service Excellence Award (2008), American Heart Association Research Excellence Award (2009), and WuXi AppTec Research Award for Life Sciences (2019). He is supported by national high level talents special support plan.

 

Dr. Wang’s research aims to elucidate the mechanisms of ischemic heart disease, with a particular focus on inflammation and thrombosis, and to translate novel mechanistic insights into therapeutic innovation. He has representative publications in Nat Commun, PNAS, J Clin Invest, Circulation, Circ Res, and ATVB. He is the chief editor of the book “Coronary Artery Disease: Therapeutics and Drug Discovery” (Springer Press).

 

 

 

Lab Website

 

http://sklcvd.fuwaihospital.org/WangM-Lab